NCT05000528

Brief Summary

20 to 30% of the general population suffers from chronic insomnia. Cognitive behavioral therapy (CBT) is the first-line treatment, but unfortunately its implementation is complex. Long waiting times for a consultation / exploration, too short a consultation period, non-reimbursement of specialists and a lack of trained staff make the current care of insomniac patients difficult. Patients are thus treated late, often with heavy drug treatment, dependence on sleeping pills, difficult withdrawal and / or reactive mood disorders. The treatment is therefore limited to advice on sleep hygiene and a restriction of time spent in bed without ultimately intervening in the cognitive domain. Therapeutic education consists of empowering the patient in the management of chronic insomnia through group education workshops. The patient learns the principles of normal sleep, the way in which sleep evolves with aging, the dangers of treatments as well as the rules of sleep hygiene and the behaviors to modify to sleep well. In addition to benefiting from sharing of experience with other patients, therapeutic education makes the care pathway smoother and considerably reduces the long waiting times of the traditional care pathway in consultation. The study investigators hypothesize that therapeutic education is more effective as a treatment for chronic insomnia than traditional management in individualized consultation (IC). Thus, therapeutic education could constitute an effective alternative to CBT.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 22, 2021

Completed
20 days until next milestone

First Posted

Study publicly available on registry

August 11, 2021

Completed
1.1 years until next milestone

Study Start

First participant enrolled

September 30, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 29, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 29, 2025

Completed
Last Updated

December 18, 2024

Status Verified

December 1, 2024

Enrollment Period

2 years

First QC Date

July 22, 2021

Last Update Submit

December 13, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Improvement in chronic insomnia between groups

    Change in Insomnia Severity Index (ISI) score (Score between 0 - 28) from inclusion

    Day 28

Secondary Outcomes (20)

  • Change in total sleeping time between groups

    Day 28

  • Change in time in bed between groups

    Day 28

  • Change in effective sleep

    Day 28

  • Change in sleep latency

    Day 28

  • Change in intra-sleep time

    Day 28

  • +15 more secondary outcomes

Study Arms (2)

Therapeutic education

EXPERIMENTAL
Other: therapeutic educationOther: Actimetry

Individualized consultation

ACTIVE COMPARATOR
Other: Actimetry

Interventions

In groups of 5-6, patients will have a one-day therapeutic training session comprising 4 workshops: how to create a sleep agenda; normal sleep; sleep hygiene; medical treatments.

Therapeutic education

once from inclusion for 2 weeks, second for 2 weeks starting 2 weeks after intervention

Individualized consultationTherapeutic education

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patient must have given their free and informed consent
  • The patient must be a member or beneficiary of a health insurance plan
  • Patient must understand and read French
  • Patient with ICSD-3 diagnostic criteria for chronic insomnia: ISI score \> 14/28.

You may not qualify if:

  • Patient with cognitive impairment as assessed by the investigator
  • Patient with shift work
  • Patients scoring \> 10/24 on the Epworth sleepiness scale
  • Patient suffering from medical or psychiatric illnesses which may, in the opinion of the investigator, compromise the subject's state of health or ability to participate in the study.
  • Patient with chronic alcohol consumption or drug abuse
  • Patient unable to express consent.
  • Pregnant, parturient or breastfeeding patient.
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de NIMES

Nîmes, 30029, France

RECRUITING

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Beatriz Abril

    Centre Hospitalier Universitaire de Nīmes

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 22, 2021

First Posted

August 11, 2021

Study Start

September 30, 2022

Primary Completion

September 29, 2024

Study Completion

September 29, 2025

Last Updated

December 18, 2024

Record last verified: 2024-12

Locations